Charles A. Sanders, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 5,000 shares at $6.66 ($33K) on 2010-02-08, disclosed to the SEC on 2010-02-09.
Open-market purchase of $33k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| VRTX | SELL | 2009-05-19 | $95K | — | Filing → |